Felipe Kellermann Hurtado
Impact in
- Physiology top 10%
- Adenosine and Purinergic Signaling
Papers in
-
- Adenosine and Purinergic Signaling 3
-
- Analytical Methods in Pharmaceuticals 3
- Co-authors
- Clarice Madalena Bueno Rolim (3 shared papers)Amer A. Beg (2 shared papers)Ben Creelan (2 shared papers)Alberto Chiappori (3 shared papers)Scott Joseph Antonia (2 shared papers)Jhanelle E. Gray (2 shared papers)Eric B. Haura (2 shared papers)Tawee Tanvetyanon (2 shared papers)
- Journals
- Annals of Oncology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Clinical Cancer Research (1 paper)Journal of Medicinal Chemistry (1 paper)Biomedical Chromatography (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Felipe Kellermann Hurtado
11 papers receiving 322 citations
Peers
Comparison fields: 5 of 38
- Physiology 37
- Drug Discovery 1
- Molecular Biology 165
- Oncology 42
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Felipe Kellermann Hurtado
This map shows the geographic impact of Felipe Kellermann Hurtado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Kellermann Hurtado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Kellermann Hurtado more than expected).
Fields of papers citing papers by Felipe Kellermann Hurtado
This network shows the impact of papers produced by Felipe Kellermann Hurtado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Kellermann Hurtado. The network helps show where Felipe Kellermann Hurtado may publish in the future.
Co-authors
The 25 scholars most cited alongside Felipe Kellermann Hurtado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 188 | |
| 2 | 2022 | 57 | |
| 3 | 2019 | 36 | |
| 4 | 2018 | 9 | |
| 5 | 2021 | 9 | |
| 6 | Microbiological Assay and HPLC Method for the Determination of Fluconazole in Pharmaceutical Injectable Formulations | 2008 | 7 |
| 7 | 2019 | 7 | |
| 8 | 2010 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2012 | 3 | |
| 11 | 2020 | 2 |
About Felipe Kellermann Hurtado
Felipe Kellermann Hurtado is a scholar working on Physiology, Analytical Chemistry, Pharmaceutical Science, Pharmacology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 328 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (3 papers), Adenosine and Purinergic Signaling (3 papers), Lung Cancer Treatments and Mutations (2 papers), Drug Solubulity and Delivery Systems (1 paper), Chromatin Remodeling and Cancer (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Physiology (37 citations), Drug Discovery (1 citation), Molecular Biology (165 citations), Oncology (42 citations) and Pulmonary and Respiratory Medicine (48 citations). Felipe Kellermann Hurtado has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Clarice Madalena Bueno Rolim, Amer A. Beg, Ben Creelan, Alberto Chiappori, Scott Joseph Antonia, Jhanelle E. Gray, Eric B. Haura, Tawee Tanvetyanon, Luigi Manenti and Erick J. Morris. Their work appears in journals such as Annals of Oncology, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Journal of Medicinal Chemistry and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.